H 92 (Metformin hydrochloride and pioglitazone hydrochloride 500 mg / 15 mg (base))

Pill imprint H 92 has been identified as Metformin hydrochloride and pioglitazone hydrochloride 500 mg / 15 mg (base).

Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 500 mg / 15 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Metformin hydrochloride and pioglitazone hydrochloride

Imprint:

H 92

Strength:

500 mg / 15 mg (base)

Color:

White

Shape:

Rectangle

Availability:

Prescription only

Drug Class:

Antidiabetic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Aurobindo Pharma Limited

National Drug Code (NDC):

65862-0525

Inactive Ingredients:

carboxymethylcellulose calcium
hydroxypropyl cellulose
hypromellose 2910 (5 mPa.s)
lactose monohydrate
magnesium stearate
polyethylene glycol 6000
magnesium silicate
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.